RE:RE:RE:RE:RE:Fair market value of strategic investmentsLook, I am the one who said, "PYR did not do .10 in EPS since all of that .10 was due to HPQ investment. They did .02 if you take out the HPQ investment".
Everyone on this board told me to Foff. The stock didn't rise at that time and NOW
it will not drop because of this negative number.
StairwayTo wrote: I hope you're right.
But you recalled the headline for Q4?
I wounder how the Q2 headline will look like. Certainly they will hide this in the fine print.
.
.
fdfd12 wrote: Wrong $1.20 to $.71.
Also it doesn't matter for the $-.11.
The market didn't care before when their earnings were +.10 caused by HPQ going up.
They won't care -.11 EPS with HPQ going down.
Market only cares for PYR and how they do.
If you look at their eranings, you need to look for "operational income or adjusted income"
That is what will move the market.
StairwayTo wrote: End of Q1 HPQ = $1.17
End of Q2 HPQ = $0.70
A drop of $0.47 which will result in a comprehensive loss of $18,000,000.
or
minus $0.11 eps Even if PYR turned
all of there backlog into revenu in Q2, they will have to show a huge loss.
I sure hope a major annoucement will bring the sp up by a $1 or $2 so I can breakeven and sell before the Q2 results announcement.
Sorry for the downer, that's how i feel.
.
.
StairwayTo wrote: I hope the $65M involves somehow HPQ that could help its sp,
Cause as of now, PYR will have to book a comprehensive loss of 12.8M in Q2
not negligible.
PYR recorded a comprehensive income of $41millions for the year ending 12/31/2020.
The result of "fair market value" on HPQ investment, which saw its SP increased from $0.08 to $1.10 by the end of 2020.
PYR will probably record some $3M in comprehensive income in Q1, due to the increase in HPQ from $1.10 to $1.17 at the end of March.
Every drop of $0.10 in HPQ sp would represent +/- $4 millions in comprehensive loss
[/quote]